Cargando…
Inhibition of eIF6 Activity Reduces Hepatocellular Carcinoma Growth: An In Vivo and In Vitro Study
Nonalcoholic fatty liver disease (NAFLD) is characterized by the accumulation of lipids in the liver. Given the high prevalence of NAFLD, its evolution to nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) is of global concern. Therapies for managing NASH-driven HCC can benefit f...
Autores principales: | Scagliola, Alessandra, Miluzio, Annarita, Mori, Giada, Ricciardi, Sara, Oliveto, Stefania, Manfrini, Nicola, Biffo, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319760/ https://www.ncbi.nlm.nih.gov/pubmed/35887068 http://dx.doi.org/10.3390/ijms23147720 |
Ejemplares similares
-
Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma
por: Scagliola, Alessandra, et al.
Publicado: (2021) -
Expression and activity of eIF6 trigger Malignant Pleural Mesothelioma growth in vivo
por: Miluzio, Annarita, et al.
Publicado: (2015) -
Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma
por: Scagliola, Alessandra, et al.
Publicado: (2023) -
Discovery and Preliminary Characterization of Translational Modulators that Impair the Binding of eIF6 to 60S Ribosomal Subunits
por: Pesce, Elisa, et al.
Publicado: (2020) -
Data on the effects of eIF6 downmodulation on the proportions of innate and adaptive immune system cell subpopulations and on thymocyte maturation
por: Manfrini, Nicola, et al.
Publicado: (2017)